Skip to Main Content

Paper Details

Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemia.
Leukemia
6
2022
Author NameAffiliation
Kristine R CrewsHematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital
Kristine R CrewsDepartment of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital
William E EvansHematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital
William E EvansSt. Jude Children's Research Hospital
William E EvansSt. Jude Children's Research Hospital
Shondra M Pruett-MillerSt. Jude Children's Research Hospital
Shondra M Pruett-MillerDepartment of Cell and Molecular Biology and Center for Advanced Genome Engineering, St. Jude Children's Research Hospital
Mary V RellingHematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital
Mary V RellingDepartment of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital
Mary V RellingSt. Jude Children's Research Hospital
William E EvansHematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital
William E EvansDepartment of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital
William E EvansSt. Jude Children's Research Hospital
  • 1 - 13

Datasets